Table 2.
Cervicovaginal fluid cytokine levels in patients in the study group and control group
| Cytokine | Delivery at <34 wk (n=23) | Delivery at ≥34 wk (n=36) | P-valueb) |
|---|---|---|---|
| MIP-1β | 18.56 (0–375.00) | 2.89 (0–301.56) | 0.067 |
| MIP-1α | 11.62 (0–309.47) | 5.73 (0–130.48) | 0.028a) |
| TNF-α | 0 (0–169.67) | 0 (0–130.66) | 0.661 |
| IL-1β | 65.35 (0–3,321.48) | 67.08 (0–2,990.27) | 0.738 |
| IL-6 | 83.27 (0–1,712.41) | 1.44 (0–956.15) | 0.002a) |
| IL-8 | 3,663.22 (234.78–10,911.85) | 3,007.72 (154.79–10,365.90) | 0.472 |
| IL-17α | 6.54 (1.51–17.97) | 4.17 (0–11.69) | 0.018a) |
| G-CSF | 38.80 (0–1,097.48) | 38.74 (0–818.30) | 0.225 |
| IL-7 | 2.81 (0–18.83) | 0 (0–19.55) | 0.064 |
Data are expressed as the median (range) (pg/mL).
MIP, macrophage inflammatory protein; TNF, tumor necrosis factor; IL, interleukin; G-CSF, granulocyte colony stimulating factor
a)
Significant difference between 2 groups (P<0.05);
b)
Using Mann-Whitney U test.